Results 301 to 310 of about 482,699 (357)

Targeting DKK3 to remodel tumor immune microenvironment and enhance cancer immunotherapy. [PDF]

BMC Cancer
Shi K, Zhao Y, Ye H, Zhu X, Chen Z.
europepmc   +1 more source

Microfluidics‐Based Microcarriers for Live‐Cell Delivery

Advanced Science, EarlyView.
In this review, recent advancements in microfluidics‐based microcarriers for live‐cell delivery are highlighted. The structural designs of microfluidic‐derived cell‐laden microcarriers are systematically categorized, emphasizing innovative approaches in the fabrication of microspheres, microfibers, and microneedles.
Zhonglin Fang, Xinyuan Yang, Chong Wang, Luoran Shang   +3 more
wiley   +1 more source

Oral garlic-derived nanoparticles improve cancer immunotherapy. [PDF]

Acta Pharm Sin B
Yang K, Zhang J, Xiao B.
europepmc   +1 more source

A Porphyrin Nanomaterial for Photoimmunotherapy for Treatment of Melanoma

Advanced Science, EarlyView.
The TPC@OVA NPs are developed as dual‐functional nanomaterials combining phototherapy and immunotherapy for melanoma treatment. This system effectively ablates primary tumors, induces immunogenic cell death, promotes dendritic cell maturation, and enhances T cell activation.
Zhuang Fan, Qing Pei, Haojie Sun, Haiyan Zhang, Zhigang Xie, Tao Zhang, Chong Ma   +6 more
wiley   +1 more source

Multifaceted functions of tissue-resident memory T cells in tumorigenesis and cancer immunotherapy. [PDF]

Cancer Immunol Immunother
Seo ES, Lee SK, Son YM.
europepmc   +1 more source

BAG2 Inhibits Cervical Cancer Progression by Modulating Type I Interferon Signaling through Stabilizing STING

Advanced Science, EarlyView.
Based on IP‐MS analysis, BAG2 is confirmed to be essential for ubiquitination and protein homeostasis regulation of STING in cervical cancer. BAG2 inhibits the ubiquitination and degradation of STING by forming a complex with STUB1, thereby activating the type I IFN signaling pathway and inhibiting the development of cervical cancer.
Shijie Yao, Siming Chen, Anjin Wang, Ziyan Liang, Xuelian Liu, Yang Gao, Hongbing Cai   +6 more
wiley   +1 more source

Bifunctional Phagocytic Synapse Enhancers for Cancer Immunotherapy

Sabatino V, Fleisch S, Tang C, Müller FM, Labão-Almeida C, Khaw WT, Hogan S, Hicks DR, Fontes M, Coelho AR, Yang W, Sarkar I, Shome D, Vidal AV, Cabeza-Cabrerizo M, Rohm T, Reijmers RM, Kaymak D, Gerster F, Baker D, Fior R, Hutter G, Bernardes GJL.   +22 more
europepmc   +1 more source

Multidimensional applications of prussian blue-based nanoparticles in cancer immunotherapy. [PDF]

J Nanobiotechnology
Zhang J, Wang F, Sun Z, Ye J, Chu H.
europepmc   +1 more source

Engineering the Immune Response to Biomaterials

Advanced Science, EarlyView.
This paper reviews immune responses to biomaterials, stages of evolution in relation to managing these responses ranging from preventing to modulating them. It also discusses state‐of‐the‐art strategies to modulate these responses and modes of their delivery.
Abolfazl Salehi Moghaddam, Mehran Bahrami, Einollah Sarikhani, Rumeysa Tutar, Yavuz Nuri Ertas, Faleh Tamimi, Ali Hedayatnia, Clotilde Jugie, Houman Savoji, Asma Talib Qureshi, Muhammad Rizwan, Chima V. Maduka, Nureddin Ashammakhi   +12 more
wiley   +1 more source

Natural killer cell engagers for cancer immunotherapy. [PDF]

Front Oncol
Nikkhoi SK, Li G, Hatefi A.
europepmc   +1 more source